Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study

Once-daily, prolonged-release tacrolimus vs twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: A Phase 4, randomized, open-label, comparative, single-center study

(2018) Min-Ho Shin et al.   CLINICAL TRANSPLANTATION

Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant

(2016) Elisabeth Cassuto et al.   TRANSPLANTATION

Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients

(2015) Seong Hoon Kim et al.   Hepatobiliary & Pancreatic Diseases International

Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations

(2015) Audrey Coilly et al.   LIVER TRANSPLANTATION

Once- Versus Twice-Daily Tacrolimus

(2011) Katherine A. Barraclough et al.   DRUGS

Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation

(2010) P. Trunečka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial

(2010) Lutz Fischer et al.   LIVER TRANSPLANTATION

Safety of Conversion From Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Stable Liver Transplant Recipients

(2010) C. Comuzzi et al.   TRANSPLANTATION PROCEEDINGS